Available Raw Materials & Active Pharmaceutical Ingredients
Licorice Root Extract
Magnesium Ascorbate 20%
Magnesium Citrate 16%
Milk Thistle Extract
Naladixic Acid Sodium Salt
Oxolinic Acid Sodium Salt
Penicillin G Procaine
Penicillin Potassium V & G
Potassium Aluminum Sulphate
Potassium Phosphate Mono
Prednisolone + Salts
Rhodiola Rosea 3%
Riboflavin 5 Phosphate Sodium
Saw Palmetto Berry Ext Power 25%
Saw Palmetto 45%
Saw Palmetto extract (CO2)
Tetracycline Base & HCI
Tribulus Terrestris Extract 40%
Tribulus Terrestris Extract 60%
Tribulus Terrestris Extract 80%
Vitamin B6 Multiple Forms
Vitamin B12 – Multiple Forms
Vitamin E Oil (Natural & Synthetic)
Vitamin E Powder (Natural & Synthetic)
Whey Protein 80%
Whey Protein 80% (Instantized)
Whey Protein 90% (Instantized)
White Willow Bark Extract
Zinc Sulphate Monohydrate
Quality and Standards:
We apply and adhere to a strict set of quality standards, and we have policies and procedures in place to identify, measure, control and sustain product-quality excellence. We continuously strive to improve these standards in order to enhance procedures and ensure ongoing compliance with current Good Manufacturing Practices (GMP).
All manufacturing facilities that Canadian National Pharma Group owns and operates, and any company from which we purchase formulated pharmaceuticals, active ingredients and sterile products, must comply with GMP. These standards include requirements for verifying the sources of incoming materials, and for the manufacturing, storage, handling and distribution of products.
Counterfeit products are a growing global problem and a serious threat to public health. We at Canadian National Pharma Group believe that maintaining the integrity of our supply chain is of paramount importance.
Canadian National Pharma Group maintains strict quality standards no matter where in the world our products are manufactured. Once we have made a decision to engage an external manufacturer, that manufacturer is required to comply with Canadian National Pharma Groups’ business requirements set forth in the contract, regardless of geography.
We conduct audits of every potential new supplier of active pharmaceutical ingredients or formulated products and sterile products to determine its acceptability and compliance with GMP.
Audits and Inspections:
We conduct Quarterly audits to further ensure that suppliers continue to meet GMP. Through such audits, we evaluate the continued acceptability of the facility from a quality assurance and regulatory compliance perspective.
Quality tests are performed on all active pharmaceutical ingredients that Canadian National Pharma Group purchases as part of our overall supplier-qualification process, and further tests are performed during subsequent stages of manufacturing. Quality tests are performed on all formulated products before we release them to the marketplace.